Displaying 121 to 140 of 143 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Santarus Inc Drug company focused on gastrointestinal diseases and disorders. |
United States | N/A |
||
|
|
Sebacia |
United States | N/A |
||
|
|
Senomyx Inc Discovery and development of innovative flavor ingredients for the food, beverage, and ingredient supply industries |
United States | N/A |
||
|
|
Sequel Pharmaceuticals Inc |
United States | N/A |
||
|
|
Sequent Medical Inc A medical device company that is dedicated to the development of innovative catheter-based devices for neurovascular specialists and their patients |
United States | 1 Mar 2012 | Series C |
|
|
|
Sequent Medical Inc A medical device company that is dedicated to the development of innovative catheter-based devices for neurovascular specialists and their patients |
United States | 1 May 2010 | Series B |
|
|
|
Sera Prognostics Inc Develop diagnostic tests for early prediction of preterm birth, preeclampsia and other pregnancy complications. |
United States | N/A |
||
|
|
SkinMedica Inc Engages developing, acquiring, and commercializing prescription and non-prescription skin care products that improve the appearance of skin. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Somaxon Pharmaceuticals Inc |
United States | N/A |
||
|
|
Sonexa Therapeutics Inc |
United States | N/A |
||
|
|
Sunesis Pharmaceuticals Inc Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and he |
United States | N/A |
||
|
|
Symphony Medical Inc |
United States | 31 Dec 2003 | Series A |
|
|
|
Syndax Pharmaceuticals Inc A clinical development company focused on novel oral therapies for cancer. |
United States | N/A |
||
|
|
Tandem Diabetes Care Inc |
United States | N/A |
||
|
|
Tobira Therapeutics Inc Dedicated to the clinical development of antiviral products |
United States | 1 Aug 2007 | Series A |
|
|
|
Tobira Therapeutics Inc Dedicated to the clinical development of antiviral products |
United States | 1 Sep 2010 | Series B |
|
|
Tragara Pharmaceuticals Inc Development of proprietary drugs for the treatment of cancer and inflammation-related disorders. |
United States | N/A |
||
|
|
Vanda Pharmaceuticals Inc Biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders. |
United States | N/A |
||
|
|
VentiRx Pharmaceuticals Inc |
United States | N/A |
||
|
|
Veracyte Inc |
United States | 11 Jun 2010 | Series B |